FDA Inspection
Carie Boyd Pharmaceuticals LLCCarie Boyd Pharmaceuticals LLC – FDA Inspection, May 12, 2017
Record Details
This FDA Inspection record concerns Carie Boyd Pharmaceuticals LLC, with an inspection on May 12, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ef9f4bb3-2f7f-4b21-84d0-4fef64161823
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1012941
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.192Quality control unit review of records
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.188(b)Batch production and Batch Control Record Requirements
- 21 CFR 211.67(b)Written procedures not established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Carie Boyd Pharmaceuticals LLC
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 8, 2026 | Not classified | Dallas District Office | Drug Quality Assurance |
| July 18, 2025 | Not classified | Dallas District Office | Drug Quality Assurance |
| June 21, 2024 | OAI | Drug Quality Assurance | |
| June 27, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 12, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Carie Boyd Pharmaceuticals LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.